Resectable_gastric_carcinoma._An_evaluation_of_preoperative_and_postoperative_chemotherapy._Patients_with_locoregional_gastric_carcinoma_often_die_because_of_the_low_rates_of_curative_resection_and_frequent_appearance_of_distant_metastases_(mainly_peritoneal_and_hepatic)._To_evaluate_the_feasibility_of_preoperative_and_postoperative_chemotherapy,_25_consecutive_previously_untreated_patients_with_potentially_resectable_locoregional_gastric_carcinoma_received_two_preoperative_and_three_postoperative_courses_of_etoposide,_5-fluorouracil,_and_cisplatin_(EFP)._Ninety-eight_courses_(median,_five_courses;_range,_two_to_five_courses)_were_administered._Six_patients_had_major_responses_to_EFP._Eighteen_patients_(72%)_had_curative_resections,_and_three_specimens_(12%)_contained_only_microscopic_carcinoma._At_a_median_follow-up_of_25_months,_the_median_survival_of_25_patients_was_15_months_(range,_4_to_32+_months)._Peritoneal_carcinomatosis_was_the_most_common_indication_of_failure._One_patient_died_of_postoperative_complications,_but_there_were_no_deaths_due_to_chemotherapy._EFP-induced_toxic_reactions_were_moderate._Preoperative_and_postoperative_chemotherapy_for_locoregional_gastric_carcinoma_is_feasible,_and_additional_studies_to_develop_regimens_that_could_result_in_5%_to_10%_complete_pathologic_responses_may_be_warranted.